-
Albà MM, Das R, Orengo CA, Kellam P, 2001: Genomewide function conservation and phylogeny in the Herpesviridae[J]. Genome Res, 11, 43-54. doi: 10.1101/gr.149801
-
Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR, 2006: Lambda interferon (IFN-λ), a type Ⅲ IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo[J]. J Virol, 80, 4501-4509. doi: 10.1128/JVI.80.9.4501-4509.2006
-
Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, 2008: An important role for type Ⅲ interferon (IFN-λ/IL-28) in TLR-induced antiviral activity[J]. J Immunol, 180, 2474-2485. doi: 10.4049/jimmunol.180.4.2474
-
Arslan M, Yang X, Santhakumar D, Liu X, Hu X, Munir M, Li Y, Zhang Z, 2019: Dynamic expression of interferon lambda regulated genes in primary fibroblasts and immune organs of the chicken[J]. Genes, 10, 145-. doi: 10.3390/genes10020145
-
Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (2007) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge
-
Berry R, Watson GM, Jonjic S, Degli-Esposti MA, Rossjohn J, 2020: Modulation of innate and adaptive immunity by cytomegaloviruses[J]. Nat Rev Immunol, 20, 113-127. doi: 10.1038/s41577-019-0225-5
-
Bibert S, Wojtowicz A, Taffé P, Manuel O, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Kaiser L, Osthoff M, 2014: The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients[J]. Aids, 28, 1885-1889. doi: 10.1097/QAD.0000000000000379
-
Bilichodmath S, Nair SK, Bilichodmath R, Mangalekar SB, 2018: mRNA expression of IFN-λs in the gingival tissue of patients with chronic or aggressive periodontitis: a polymerase chain reaction study[J]. J Periodontol, 89, 867-874. doi: 10.1002/JPER.17-0349
-
Bin L, Li X, Richers B, Streib JE, Hu JW, Taylor P, Leung DY, 2018: Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum[J]. J Allergy Clin Immunol, 14, e2081-. doi: 10.1016/j.jaci.2018.01.001
-
Blumer T, Coto-Llerena M, Duong FH, Heim MH, 2017: SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)-induced gene expression in vivo[J]. J Biol Chem, 292, 17928-17938. doi: 10.1074/jbc.M117.788877
-
Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte J-M, Diebold J, Diepolder H, Adler B, Auernhammer CJ, 2005: IL-28A and IL-29 Mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic expression[J]. Am J Physiol Gastrointest Liver Physiol, 289, 960-968. doi: 10.1152/ajpgi.00126.2005
-
Bravo D, Solano C, Giménez E, Remigia MJ, Corrales I, Amat P, Navarro D, 2014: Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients[J]. J Med Virol, 86, 838-844. doi: 10.1002/jmv.23865
-
Chen S, Zhang W, Zhou Q, Wang A, Sun L, Wang M, Jia R, Zhu D, Liu M, Sun K, 2017: Cross-species antiviral activity of goose interferon lambda against duck plague virus is related to its positive self-regulatory feedback loop[J]. J Gen Virol, 98, 1455-1466. doi: 10.1099/jgv.0.000788
-
Costa AS, Agostini S, Guerini FR, Mancuso R, Zanzottera M, Ripamonti E, Racca V, Nemni R, Clerici M, 2017: Modulation of immune responses to herpes simplex virus type 1 by IFNL3 and IRF7 polymorphisms: a study in Alzheimer's disease[J]. J Alzheimer's Dis, 60, 1055-1063. doi: 10.3233/JAD-170520
-
Dağ F, Dölken L, Holzki J, Drabig A, Weingärtner A, Schwerk J, Lienenklaus S, Conte I, Geffers R, Davenport C, 2014: Reversible silencing of cytomegalovirus genomes by type i interferon governs virus latency[J]. PLoS Pathog, 10, e1003962-. doi: 10.1371/journal.ppat.1003962
-
Danastas K, Miranda-Saksena M, Cunningham AL, 2020: Herpes Simplex Virus Type 1 Interactions with the Interferon System[J]. Int J Mol Sci, 21, 5150-. doi: 10.3390/ijms21145150
-
De Pelsmaeker S, Romero N, Vitale M, Favoreel HW, 2018: Herpesvirus evasion of natural killer cells[J]. J Virol, 92, e2105-e2117.
-
De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW, 2010: Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro[J]. PloS one, 5, e13076-. doi: 10.1371/journal.pone.0013076
-
Ding S, Khoury-Hanold W, Iwasaki A, Robek MD, 2014: Epigenetic reprogramming of the type Ⅲ interferon response potentiates antiviral activity and suppresses tumor growth[J]. PLoS Biol, 12, e1001758-. doi: 10.1371/journal.pbio.1001758
-
Donnelly RP, Kotenko SV, 2010: Interferon-lambda: a new addition to an old family[J]. J Interferon Cytokine Res, 30, 555-564. doi: 10.1089/jir.2010.0078
-
Egli A, Levin A, Santer DM, Joyce M, O'Shea D, Thomas BS, Lisboa LF, Barakat K, Bhat R, Fischer KP, 2014: Immunomodulatory function of interleukin 28B during primary infection with cytomegalovirus[J]. J Infect Dis, 210, 717-727. doi: 10.1093/infdis/jiu144
-
Enquist LW, Leib DA, 2017: Intrinsic and innate defenses of neurons: Detente with the herpesviruses[J]. J Virol, 91, -.
-
Fan W, Xie S, Zhao X, Li N, Chang C, Li L, Yu G, Chi X, Pan Y, Niu J, 2016: IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis c through long-term induction of USP18[J]. J Gen Virol, 97, 2210-2220. doi: 10.1099/jgv.0.000522
-
Fernández-Ruiz M, Corrales I, Amat P, González E, Andrés A, Navarro D, Aguado J, 2015: Influence of age and HLA Alleles on the CMV-specific cell-mediated immunity among CMV-seropositive kidney transplant candidates[J]. Am J Transplant Off J Am Soc Transplante Am Soc Transplant Surg, 15, 2525-2526. doi: 10.1111/ajt.13370
-
Fuld S, Cunningham C, Klucher K, Davison AJ, Blackbourn DJ, 2006: Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein[J]. J Virol, 80, 3092-3097. doi: 10.1128/JVI.80.6.3092-3097.2006
-
García-Sastre A, 2017: Ten strategies of interferon evasion by viruses[J]. Cell Host Microbe, 22, 176-184. doi: 10.1016/j.chom.2017.07.012
-
Gimeno Brias S, Marsden M, Forbester J, Clement M, Brandt C, Harcourt K, Kane L, Chapman L, Clare S, Humphreys IR, 2018: Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection[J]. PLoS ONE, 13, e0197596-. doi: 10.1371/journal.pone.0197596
-
Gonzalez-Perez AC, Stempel M, Chan B, Brinkmann MM, 2020: One step ahead: herpesviruses Light the Way to Understanding Interferon-Stimulated Genes (ISGs)[J]. Front Microbiol, 11, 124-. doi: 10.3389/fmicb.2020.00124
-
Griffiths SJ, Koegl M, Boutell C, Zenner HL, Crump CM, Pica F, Gonzalez O, Friedel CC, Barry G, Martin K, 2013: A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication[J]. PLoS Pathog, 9, e1003514-. doi: 10.1371/journal.ppat.1003514
-
Grinde B, 2013: Herpesviruses: latency and reactivation-viral strategies and host response[J]. J Oral Microbiol, 5, 22766-. doi: 10.3402/jom.v5i0.22766
-
Huang M, Jiang J-D, Peng Z, 2014: Recent advances in the anti-HCV mechanisms of interferon[J]. Acta Pharmaceutica Sinica B, 4, 241-247. doi: 10.1016/j.apsb.2014.06.010
-
Iversen MB, Ank N, Melchjorsen J, Paludan SR, 2010: Expression of type Ⅲ interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-κB than type Ⅰ IFNs[J]. J Virol, 84, 4579-4586. doi: 10.1128/JVI.02591-09
-
Jacobs S, Zeippen C, Wavreil F, Gillet L, Michiels T, 2019: IFN-λ Decreases Murid Herpesvirus-4 infection of the olfactory epithelium but fails to prevent virus reactivation in the vaginal mucosa[J]. Viruses, 11, 757-. doi: 10.3390/v11080757
-
Jahanban-Esfahlan R, Seidi K, Majidinia M, Karimian A, Yousefi B, Nabavi SM, Astani A, Berindan-Neagoe I, Gulei D, Fallarino F, 2019: Toll-like receptors as novel therapeutic targets for herpes simplex virus infection[J]. Rev Med Virol, 29, e2048-. doi: 10.1002/rmv.2048
-
Jayanthi D, Faizuddin M, Noor Ahamadi H, 2017: Association of interferon lambda-1 with herpes simplex viruses-1 and-2, Epstein-Barr virus, and human cytomegalovirus in chronic periodontitis[J]. J Investig Clin Dent, 8, e12200-. doi: 10.1111/jicd.12200
-
Johnston C, Gottlieb SL, Wald A, 2016: Status of vaccine research and development of vaccines for herpes simplex virus[J]. Vaccine, 34, 2948-2952. doi: 10.1016/j.vaccine.2015.12.076
-
Jones C, 2019: Bovine herpesvirus 1 counteracts immune responses and immune-surveillance to enhance pathogenesis and virus transmission[J]. Front Immunol, 10, 1008-. doi: 10.3389/fimmu.2019.01008
-
Karpala AJ, Morris KR, Broadway MM, McWaters PG, O'Neil TE, Goossens KE, Lowenthal JW, Bean AG, 2008: Molecular cloning, expression, and characterization of chicken IFN-λ[J]. J Interferon Cytokine Res, 28, 341-350. doi: 10.1089/jir.2007.0117
-
Kim J-A, Park S-K, Seo S-W, Lee C-H, Shin OS, 2017: STING is involved in antiviral immune response against VZV infection via the induction of type Ⅰ and Ⅲ IFN pathways[J]. J Investig Dermatol, 137, 2101-2109. doi: 10.1016/j.jid.2017.03.041
-
Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP, 2003: IFN-λs mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex[J]. Nat Immunol, 4, 69-77.
-
Koyuncu OO, MacGibeny MA, Enquist LW, 2018: Latent versus productive infection: The alpha herpesvirus switch[J]. Future Virol, 13, 431-443. doi: 10.2217/fvl-2018-0023
-
Kuhs KAL, Kuniholm MH, Pfeiffer RM, Chen S, Desai S, Edlin BR, Peters MG, Plankey M, Sharp GB, Strickler HD, 2015: Interferon lambda 4 genotype is not associated with recurrence of oral or genital herpes[J]. PLoS ONE, 10, e0138827-. doi: 10.1371/journal.pone.0138827
-
La Rosa F, Agostini S, Bianchi A, Nemni R, Piancone F, Marventano I, Mancuso R, Saresella M, Clerici M, 2019: Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients[J]. J Translat Med, 17, 286-. doi: 10.1186/s12967-019-2034-9
-
Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, Nischalke HD, Nattermann J, Oldenburg J, Sauerbruch T, Spengler U, 2011: Interferon-lambda serum levels in hepatitis C[J]. J Hepatol, 54, 859-865. doi: 10.1016/j.jhep.2010.08.020
-
Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, Freudenberg MA, Davey GM, Vremec D, Kallies A, 2010: Mouse CD8α+DCs and human BDCA3+DCs are major producers of IFN-λ in response to poly IC[J]. J Exp Med, 207, 2703-2717. doi: 10.1084/jem.20092720
-
Li J, Hu S, Zhou L, Ye L, Wang X, Ho J, Ho W, 2011: Interferon lambda inhibits herpes simplex virus type Ⅰ infection of human astrocytes and neurons[J]. Glia, 59, 58-67. doi: 10.1002/glia.21076
-
Li J, Ye L, Wang X, Hu S, Ho W, 2012: Induction of interferon-λ contributes to toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes[J]. J Neurosci Res, 90, 399-406. doi: 10.1002/jnr.22758
-
Li Z, Lu X, Zhu Y, Cheng P, Liu S, Zhang Y, Tang J, Yang S, Zhou L, 2017: Lambda-interferons inhibit herpes simplex virus type 2 replication in human cervical epithelial cells through activation of JAK/STAT pathway[J]. Jpn J Infect Dis JJID, 2016, 2465-. doi: 10.7883/yoken.JJID.2016.465
-
Linderman JA, Kobayashi M, Rayannavar V, Fak JJ, Darnell RB, Chao MV, Wilson AC, Mohr I, 2017: Immune escape via a transient gene expression program enables productive replication of a latent pathogen[J]. Cell Rep, 18, 1312-1323. doi: 10.1016/j.celrep.2017.01.017
-
Liu F, Liu C, Hu X, Shang Y, Wu L, 2017: MicroRNA-21: a positive regulator for optimal production of type Ⅰ and type Ⅲ interferon by plasmacytoid dendritic cells[J]. Front Immunol, 8, 947-. doi: 10.3389/fimmu.2017.00947
-
Liu Q, Rao Y, Tian M, Zhang S, Feng P, 2019: Modulation of innate immune signaling pathways by herpesviruses[J]. Viruses, 11, 572-. doi: 10.3390/v11060572
-
Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM, 2015: Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012[J]. PLoS ONE, 10, e0140765-. doi: 10.1371/journal.pone.0140765
-
Lopušná K, Režuchová I, Kabat P, Kúdelová M, 2014: Interferon lambda induces antiviral response to herpes simplex virus 1 infection[J]. Acta Virol, 58, 325-332. doi: 10.4149/av_2014_03_325
-
Lopušná K, Benkóczka T, Lupták J, Matúšková R, Lukáčiková L', Ovečková I, Režuchová I, 2016: Murine gammaherpesvirus targets type Ⅰ IFN receptor but not type Ⅲ IFN receptor early in infection[J]. Cytokine, 83, 158-170. doi: 10.1016/j.cyto.2016.04.013
-
Manuel O, Wójtowicz A, Bibert S, Mueller NJ, Van Delden C, Hirsch HH, Steiger J, Stern M, Egli A, Garzoni C, 2015: Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation[J]. J Infect Dis, 211, 906-914. doi: 10.1093/infdis/jiu557
-
Megjugorac NJ, Gallagher GE, Gallagher G, 2009: Modulation of human plasmacytoid DC function by IFN-λ1 (IL-29)[J]. J Leukoc Biol, 86, 1359-1363. doi: 10.1189/jlb.0509347
-
Megjugorac NJ, Gallagher GE, Gallagher G, 2010: IL-4 enhances IFN-λ1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra[J]. Blood J Am Soc Hematol, 115, 4185-4190. doi: 10.1182/blood-2009-09-246157
-
Melchjorsen J, Siren J, Julkunen I, Paludan SR, Matikainen S, 2006: Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-κB and IRF-3[J]. J Gen Virol, 87, 1099-1108. doi: 10.1099/vir.0.81541-0
-
Melchjorsen J, Rintahaka J, Søby S, Horan KA, Poltajainen A, Østergaard L, Paludan SR, Matikainen S, 2010: Early innate recognition of herpes simplex virus in human primary macrophages is mediated via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase Ⅲ-independent pathways[J]. J Virol, 84, 11350-11358. doi: 10.1128/JVI.01106-10
-
Murray MJ, Peters NE, Reeves MB, 2018: Navigating the host cell response during entry into sites of latent cytomegalovirus infection[J]. Pathogens, 7, 30-. doi: 10.3390/pathogens7010030
-
Nordström I, Eriksson K, 2012: HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9[J]. PLoS ONE, 7, e38683-. doi: 10.1371/journal.pone.0038683
-
Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, Boulant S, Gehrke L, Cossart P, Kagan JC, 2014: Diverse intracellular pathogens activate type Ⅲ interferon expression from peroxisomes[J]. Nat Immunol, 15, 717-. doi: 10.1038/ni.2915
-
Onabajo OO, Muchmore B, Prokunina-Olsson L, 2019: The IFN-λ4 conundrum: when a good interferon goes bad[J]. J Interferon Cytokine Res, 39, 636-641. doi: 10.1089/jir.2019.0044
-
Paquin A, Onabajo OO, Tang W, Prokunina-Olsson L, 2016: Comparative functional analysis of 12 mammalian IFN-λ4 orthologs[J]. J Interferon Cytokine Res, 36, 30-36. doi: 10.1089/jir.2015.0096
-
Pica F, Volpi A, Gaziano R, Garaci E, 2010: Interferon-λ in immunocompetent individuals with a history of recurrent herpes labialis[J]. Antiviral Therapy, 15, 737-. doi: 10.3851/IMP1610
-
Pontejo SM, Murphy PM, Pease JE, 2018: Chemokine subversion by human herpesviruses[J]. J Innate Immun, 10, 465-478. doi: 10.1159/000492161
-
Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, 2013: A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus[J]. Nat Genet, 45, 164-171. doi: 10.1038/ng.2521
-
Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, 2003: IL-28, IL-29 and their class Ⅱ cytokine receptor IL-28R[J]. Nat Immunol, 4, 63-68. doi: 10.1038/ni873
-
Song R, Koyuncu OO, Greco TM, Diner BA, Cristea IM, Enquist LW, 2016: Two modes of the axonal interferon response limit alphaherpesvirus neuroinvasion[J]. mBio, 7, e02145-15-. doi: 10.1128/mBio.02145-15
-
Sorgeloos F, Kreit M, Hermant P, Lardinois C, Michiels T, 2013: Antiviral type ⅰ and type ⅲ interferon responses in the central nervous system[J]. Viruses, 5, 834-857. doi: 10.3390/v5030834
-
Steed AL, Barton ES, Tibbetts SA, Popkin DL, Lutzke ML, Rochford R, Virgin HW, 2006: Gamma interferon blocks gammaherpesvirus reactivation from latency[J]. J Virol, 80, 192-200. doi: 10.1128/JVI.80.1.192-200.2006
-
Su C, Zhan G, Zheng C, 2016: Evasion of host antiviral innate immunity by HSV-1, an update[J]. Virol J, 13, 1-9. doi: 10.1186/s12985-015-0456-4
-
Sun C, Luecke S, Bodda C, Jønsson KL, Cai Y, Zhang B-C, Jensen SB, Nordentoft I, Jensen JM, Jakobsen MR, 2019: Cellular requirements for sensing and elimination of incoming HSV-1 DNA and capsids[J]. J Interferon Cytokine Res, 39, 191-204. doi: 10.1089/jir.2018.0141
-
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'hUigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, 2009: Genetic variation in IL28B and spontaneous clearance of hepatitis C virus[J]. Nature, 461, 798-801. doi: 10.1038/nature08463
-
Thomson SJ, Goh FG, Banks H, Krausgruber T, Kotenko SV, Foxwell BM, Udalova IA, 2009: The role of transposable elements in the regulation of IFN-λ1 gene expression[J]. Proc Natl Acad Sci, 106, 11564-11569. doi: 10.1073/pnas.0904477106
-
Tognarelli EI, Palomino TF, Corrales N, Bueno SM, Kalergis AM, González PA, 2019: Herpes simplex virus evasion of early host antiviral responses[J]. Front Cellular Infect Microbiol, 9, 127-. doi: 10.3389/fcimb.2019.00127
-
Wells AI, Coyne CB, 2018: Type Ⅲ interferons in antiviral defenses at barrier surfaces[J]. Trends Immunol, 39, 848-858. doi: 10.1016/j.it.2018.08.008
-
Ye L, Schnepf D, Staeheli P, 2019: Interferon-λ orchestrates innate and adaptive mucosal immune responses[J]. Nat Rev Immunol, 19, 614-625. doi: 10.1038/s41577-019-0182-z
-
Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, Lewis-Antes A, Amrute SB, Garrigues U, Doyle S, 2012: Type Ⅲ IFNs are produced by and stimulate human plasmacytoid dendritic cells[J]. J Immunol, 189, 2735-2745. doi: 10.4049/jimmunol.1102038
-
Zanoni I, Granucci F, Broggi A, 2017: Interferon (IFN)-λ takes the helm: immunomodulatory roles of type Ⅲ IFNs[J]. Front Immunol, 8, 1661-. doi: 10.3389/fimmu.2017.01661
-
Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, 2007: TLR3 deficiency in patients with herpes simplex encephalitis[J]. Science, 317, 1522-1527. doi: 10.1126/science.1139522
-
Zhang S-Q, Zhang Z, Luo X, Yang S, Chai Y, Huang H-L, Yin X-Y, Hu D-J, Yang C-J, Liu J-L, 2011: Interleukin 29 enhances expression of Toll receptor 3 and mediates antiviral signals in human keratinocytes[J]. Inflamm Res, 60, 1031-. doi: 10.1007/s00011-011-0364-z
-
Zhang S-Y, Abel L, Casanova J-L (2013) Mendelian predisposition to herpes simplex encephalitis. In: Handbook of Clinical Neurology, vol 112. Elsevier, pp 1091–1097.
-
Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R, 2007: Type Ⅲ interferon (IFN) induces a type Ⅰ IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases[J]. J Virol, 81, 7749-7758. doi: 10.1128/JVI.02438-06
-
Zhou L, Li J, Wang X, Ye L, Hou W, Ho J, Li H, Ho W, 2011: IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons[J]. J Neurovirol, 17, 212-219. doi: 10.1007/s13365-011-0031-8
-
Zhou L, Li J-L, Zhou Y, Liu J-B, Zhuang K, Gao J-F, Liu S, Sang M, Wu J-G, Ho W-Z, 2015: Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells[J]. Mhr Basic Sci Reprod Med, 21, 917-929. doi: 10.1093/molehr/gav058
-
Zhou Y, Wang Z, Xu Y, Zhang Z, Hua R, Liu W, Jiang C, Chen Y, Yang W, Kong W, 2017: Optimized DNA vaccine enhanced by adjuvant IL28B induces protective immune responses against herpes simplex virus type 2 in mice[J]. Viral Immunol, 30, 601-614. doi: 10.1089/vim.2017.0033